Skip navigation

CBI’s 2nd Annual Bio/Pharmaceutical Conference on New Product Forecasting

Develop Innovative Forecasting Models to Mitigate Risk and Ensure Accurate Market Projections

June 26-27, 2012
  • Philadelphia, Pennsylvania

Agenda

Want more agenda details? Request the brochure
Tuesday June 26, 2012
7:30 am

Conference Registration and Continental Breakfast Hosted by Inpharmation


8:25 am

Chairman's Welcome and Opening Remarks

Bob Falcon
Associate Director, Business Development and Pipeline Forecasting, Specialty Generics and Devices
Endo Pharmaceuticals

8:45 am

Keynote Address • Reinventing the Business — What Is the New Target Product Profile (nTPP)?

Shacker Mourad R.Ph, MBA
President, NoahsPharm; Leadership Communication Instructor, University of Pennsylvania, Wharton Business School; Staff In-Patient Pharmacist, Veterans Administration; Adjunct Professor, Pharmaceutical and Healthcare Marketing
University of the Sciences in Philadelphia

9:30 am

Case Studies • Understand the Critical Difference between Forecasting Analogues and Forecasting Models

Gary Johnson
Managing Director
Inpharmation Ltd.

10:15 am

Networking and Refreshment Break


10:45 am

Streamline the New Product Forecasting Process in the Oncology Market

Ethan Buckley
Associate Director, New Product Analysis
Astellas Pharma US, Inc.

11:30 am

Case Studies • The Data Drought — New Product Planning for Orphan and Rare Diseases

Peter Edinburg
Former Associate Director, Forecasting
Optimer Pharmaceuticals

12:15 pm

Networking Luncheon


1:30 pm

Risk-Based Modeling — Alternative Approaches to Measuring Uncertainty for Improved Accuracy in New Product Forecasts

Thomas Foster Ph.D.
Partner
Foster Rosenblatt
Jerry A. Rosenblatt Ph.D.
Partner
Foster Rosenblatt

1:30 pm

Risk-Based Modeling — Alternative Approaches to Measuring Uncertainty for Improved Accuracy in New Product Forecasts

Thomas Foster Ph.D.
Partner
Foster Rosenblatt
Jerry A. Rosenblatt Ph.D.
Partner
Foster Rosenblatt

3:00 pm

Networking and Refreshment Break


3:30 pm

Develop a Market Research Framework for Consistent New Product Forecasting

Stephen Fleming
Principal
Trinity Partners, LLC

4:15 pm

Improve Cross-Department Collaboration in the New Product Forecasting Process to Make Critical Go/No-Go Decisions

Don Miners
Associate Director, Strategic Forecasting
Endo Pharmaceuticals

5:00 pm - 6:00 pm

Networking Wine & Cheese Reception


Wednesday June 27, 2012
7:45 am

Continental Breakfast Hosted by National Analyst


8:30 am

Chairman's Review of Day One

Bob Falcon
Associate Director, Business Development and Pipeline Forecasting, Specialty Generics and Devices
Endo Pharmaceuticals

8:45 am

Day Two Opening Address • Predicting the Unpredictable — Examine the Future of Healthcare Reform and Managed Markets on New Products

Kim Slocum
President
KDS Consulting

9:30 am

Risk Assessment and Management for New Product Planning

Bob Falcon
Associate Director, Business Development and Pipeline Forecasting, Specialty Generics and Devices
Endo Pharmaceuticals

10:15 am

Networking and Refreshment Break


10:45 pm

Static vs. Dynamic Forecasting – The Impact of Market Levers on Revenue Projections

Michael Polster Ph.D.
Senior Vice President, Healthcare Practice
National Analysts Worldwide

11:30 am

Leverage Simulation-Based Patient Modeling to Test Key Assumptions for New Product Forecasts

Zhen Tang
Director, Industry Insights
Bristol-Myers Squibb

12:15 pm

Networking Luncheon


1:30 pm

New Product Forecasting in the Era of Personalized Medicine

Michael Epstein
Director and Practice Leader, Commercial Strategy Practice
UBC

2:15 pm

Panel Discussion • Industry in the Midst of Change — Assess the Impact of the Patent Cliff on New Product Planning

Peter Edinburg
Former Associate Director, Forecasting
Optimer Pharmaceuticals
Leo MacDonald
Director, Global Strategic Analytics
Johnson & Johnson
Zhen Tang
Director, Industry Insights
Bristol-Myers Squibb
Diane Waters
New Product Planning Cardiometabolic Senior Manager, Market Research
Daiichi Sankyo

2:15 pm

Panel Discussion • Industry in the Midst of Change — Assess the Impact of the Patent Cliff on New Product Planning

Peter Edinburg
Former Associate Director, Forecasting
Optimer Pharmaceuticals
Leo MacDonald
Director, Global Strategic Analytics
Johnson & Johnson
Zhen Tang
Director, Industry Insights
Bristol-Myers Squibb
Diane Waters
New Product Planning Cardiometabolic Senior Manager, Market Research
Daiichi Sankyo

2:15 pm

Panel Discussion • Industry in the Midst of Change — Assess the Impact of the Patent Cliff on New Product Planning

Peter Edinburg
Former Associate Director, Forecasting
Optimer Pharmaceuticals
Leo MacDonald
Director, Global Strategic Analytics
Johnson & Johnson
Zhen Tang
Director, Industry Insights
Bristol-Myers Squibb
Diane Waters
New Product Planning Cardiometabolic Senior Manager, Market Research
Daiichi Sankyo

2:15 pm

Panel Discussion • Industry in the Midst of Change — Assess the Impact of the Patent Cliff on New Product Planning

Peter Edinburg
Former Associate Director, Forecasting
Optimer Pharmaceuticals
Leo MacDonald
Director, Global Strategic Analytics
Johnson & Johnson
Zhen Tang
Director, Industry Insights
Bristol-Myers Squibb
Diane Waters
New Product Planning Cardiometabolic Senior Manager, Market Research
Daiichi Sankyo

3:15 pm

Close of Conference


Agenda

Want more agenda details? Request the brochure